Treatments targeting the T cell receptor (TCR): Effects of TCR peptide-specific T cells on activation, migration, and encephalitogenicity of myelin basic protein-specific T cells

Springer Seminars in Immunopathology

Volumn 21, Issue 1, 1999, Pages 77-90

  Offner, Halina ^a,b   Jacobs, Ray ^a   Bebo Jr , Bruce F ^a,b   Vandenbark, Arthur A ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENCEPHALITOGENIC PROTEIN; L SELECTIN; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; VACCINE;

ADOPTIVE TRANSFER; ALLOTYPE; ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MYELIN BASIC PROTEINS; PEPTIDES; RATS; RATS, INBRED BUF; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0033022381     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002810050053     Document Type: Article

References (66)

1. 1. Alvord EC Jr (1984) Species-restricted encephalitogenic determinants. In: Alvord EC Jr, Kies MW, Suckling AJ (eds) Experimental allergic encephalomyelitis: a useful model for multiple sclerosis. Liss, New York, pp 523
2. 2. Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11 : 195
3. 3. Bernaud E, Reshef T, Vandenbark AA, Offner H, Fritz R, Chou CH, Bernard D, Cohen IR (1986) Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen presenting cells influences immunodominant epitope of basic protein. J Immunol 136 : 511
4. 4. Bourdette DN, Vainiene M, Morrison WJ, Jones R, Turner J, Hashim GA, Vandenbark AA, Offner H (1991) Myelin basic protein specific T cell lines and clones derived from the central nervous system of rats with experimental autoimmune encephalomyelitis only recognize encephalitogenic epitopes. J Neurosci Res 30 : 308
5. 5. Clayton JP, Gammon GM, Ando DG, Kono DH, Hood L, Sercarz EE (1989) Peptide-specific prevention of experimental allergic encephalomyelitis: neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med 169 : 1681
6. 6. Critchfield JM, Racke MK, Zuniga-Pflucker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263 : 1139
7. 7. Deibler GE, Martenson RE, Kies MW (1972) Large-scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep Biochem 2 : 139
8. 8. De Magistris MT, Alexander J, Coggeshall M, et al (1992) Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68 : 625
9. 9. Evavold BD, Sloan LJ, Allen PM (1993) Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 14 : 602
10. 10. Falb D, Briner TJ, Sunshine GH, et al (1996) Peripheral tolerance in T cell receptor-transgenic mice: Evidence for T cell anergy. Eur J Immunol 26 : 130
11. 11. Falcioni F, Vidovic D, Ward ES, Bolin D, Singh G, Shah H, Ober B, Nagy ZA (1995) Self tolerance to T cell receptor VB sequences. J Exp Med 182 : 249
12. 12. Gaur A, Wiers B, Liu A, Rothbard J, Fathman CG (1992) Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258 : 1491
13. 13. Gautam AM, Pearson CI, Smilek DE, Steinman L, McDevitt HO (1992) A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis. J Exp Med 176 : 605
14. 14. Gershon RK, Kondo K (1971) Infectious immunological tolerance. Immunology 21 : 903
15. 15. Gregerson DS, Orbitsch WF, Donoso LA (1993) Oral tolerance in experimental autoimmune uveoretinilis: distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 151 : 5751
16. 16. Heber-Katz E, Acha-Orbea H (1989) The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today 10 : 164
17. 17. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28 : 254
18. 18. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246 : 668
19. 19. Jenkins MK, Schwartz, RH (1944) Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165 : 302
20. 20. Karin N, Mitchell DJ, Brocke S, Ling N, Steinman L (1994) Reversal of experimental autoimmune eneephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J Exp Med 180 : 2227
21. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J Immunol 146 : 1163
22. 22. Kearney ER, Pape KA, Loh DY, Jenkins MK (1994) Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1 : 327
23. 23. Khoury SJ, Gallon L, Chen W, Betres K, Russell ME, Hancock WW, Carpenter CB, Sayegh MH, Weiner HL (1995) Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 182 : 357
24. 24. Kuhrober A, Schirmbeck R, Reimann J (1994) Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL. Eur J Immunol 24 : 1172
25. 25. Kumar V, Urban JL, Horvath SJ, Hood L (1990) Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 87 : 1337
26. 26. Kumar V, Stellrecht K, Sercarz E (1996) Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J Exp Med 184 : 1609
27. + T lymphocytes. J Immunol 142 : 748
28. 28. Linington C, Berger T, Perry L, et al. (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23 : 1364
29. 29. Mattingly JA, Waksman BH (1978) Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol 121 : 1878
30. 30. Metzler B, Wraith DC (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 5 : 1159
31. 31. Miller A, Zhang ZJ, Sobel RA, Al-Sabbagh A, Weiner HL (1993) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J Neuroimmunol 46 : 73
32. 32. Miller SD, Karpus WJ (1994) The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 15 : 356
33. 33. Moudgil KD, Sercarz EE (1994) The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin Immunol Immunopathol 73 : 283
34. 34. Nihira S-I, Falcioni F, Juretic A, Bolin D, Nagy ZA (1996) Induction of class II major histocompatibility complex blockade as well as T cell tolerance by peptides administered in soluble form. Eur J Immunol 26 : 1736
35. 35. Offner H, Hashim GA, Vandenbark AA (1991) T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251 : 430
36. 36. Offner H, Buenafe AC, Vainiene M, Celnik B, Weinberg AD, Gold DP, Hashim G, Vandenbark AA (1993) Where, when and how to detect biased expression of disease-relevant VB genes in rats with experimental autoimmune encephalomyelitis. J Immunol 151 : 506
37. 37. Offner H, Hashim G, Chou YK, Bourdette D, Vandenbark AA (1993) Prevention, suppression, and treatment of EAE with a synthetic T cell receptor V region peptide. In: Alt FW, Vogel MG (eds) Molecular mechanisms of immunological self-recognition. Academic Press, New York. pp 199-230
38. 38. Offner H, Vainiene M, Celnik B, Weinberg AD, Buenafe A, Vandenbark AA (1994) Co-culture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis. J Immunol 153 : 4988
39. 39. Offner H, Hashim GA, Vandenbark AA (1994) Immunity to T cell receptor peptides: theory and applications. Regul Pept 51 : 77
40. 40. Offner H, Adlard K, Bebo BF Jr, Schuster J, Burrows GG, Buenafe AC, Vandenbark AA (1998) Vaccination with BV8S2 protein amplifies TCR specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice. J Immunol 161 : 2178
41. 41. Peterson JD, Karpus WJ, Clatch RJ, Miller SD (1993) Split tolerance to Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 23 : 46
42. 42. Qin Y, Sun D, Goto M, Meyermann R, Wekerle H (1989) Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes. Eur J Immunol 19 : 373
43. 43. Quill H, Schwartz RH (1987) Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 138 : 3704
44. 44. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7 : 592
45. 45. Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23 : 339
46. 46. Sharma SD, Nag B, Su X-M, Green D, Spack E, Clark BR, Sriram S (1991) Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci USA 88 : 11465
47. 47. Singh RR, Hahn BH, Sercarz EE (1996) Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J Exp Med 183 : 1613
48. 48. Spack EG, McCutcheon M, Corbelletta N, Nag B, Passmore D, Sharma SD (1995) Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II: acetylcholine receptor peptide complexes. J Autoimmun 8 : 787
49. 49. Streilein JW, Ksander BP, Taylor AW (1997) Immune deviation in relation to ocular immune privilege. J Immunol 158 : 3557
50. 50. Strejan GH, St. Louis J (1990) Suppression of experimental allergic encephalomyelitis by MBP-liposomes: a comparison. Cell Immunol 127 : 284
51. 51. Tian J, Atkinson MA, Clare-Salzler M, et al (1996) Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183 : 1561
52. 52. Tuohy VK, Lu Z, Sobel RA, Lauresen RA, Lees MB (1989) Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142 : 1523
53. 53. Vainiene M, Gold DP, Celnik B, Hashim GA, Vandenbark AA, Offner H (1996) Natural immunodominant and EAE-protective determinants within the Lewis rat VB8.2 sequence include CDR2 and framework 3 idiotopes. J Neurosci Res 43 : 137
54. 54. Vandenbark AA, Hashim G, Offner H (1989) Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341 : 541
55. 55. Vandenbark AA, Vainiene M, Celnik B, Hashim GA, Buenafe A, Offner H (1994) Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides. J Immunol 153 : 852
56. 56. Vandenbark AA, Celnik B, Vainiene M, Miller SD, Offner H (1995) Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. J Immunol 155 : 5861
57. 57. Vandenbark AA, Hashim GA, Offner H (1996) T cell receptor peptides in treatment of autoimmune disease: rationale and potential. J Neurosci Res 43 : 391
58. 58. Vandenbark AA, Chou YK, Whitham R, Mass M, Buenafe A, Liefeld D, Kavanagh D, Cooper S, Hashim GA, Offner H, Bourdette DN (1996) Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med 2 : 1109
59. 59. Vandenbark AA, Chou YK, Bourdette DN, Whitham R, Offner H (1997) Immunogenicity is critical to the therapeutic application of T cell receptor peptide. Drug News Persp 10 : 341
60. + population during recovery. J Neuroimmunol 48 : 105
61. 61. Weinberg AD, Wallin JJ, Jones RE, Sullivan TJ, Bourdette DN, Vandenbark AA, Offner H (1994) Target organ specific upregulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J Immunol 152 : 4712
62. 62. Weiner HL, Friedman A, Miller A, et al (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12 : 809
63. 63. Whitacre CC, Bitar DM, Gienapp IE, Orosz CG (1991) Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147 : 2155
64. 64. Windhagen A, Scholz C, Hollsberg P, Fukaura H, Sette A, Hafler DA (1995) Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2 : 373
65. 65. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoímmune encephalomyelitis by antibodies against α4/β1 integrin. Nature 356 : 63
66. 66. Zhao M-L, Xia J-Q, Fritz RB (1993) Interleukin-3 and encephalitogenic activity of SJL/J myelin basic protein-specific T cell lines. J Neuroimmunol 43 : 69